Low dosage hydrate inhibitor

Patent metadata

Field	Value
Publication number	US-11760916-B2
Application number	US-201917419126-A
Country	US
Kind code	B2
Filing date	Jan 31, 2019
Priority date	Jan 31, 2019
Publication date	Sep 19, 2023
Grant date	Sep 19, 2023

Abstract

A low dosage hydrate inhibitor blend comprising a cationic surfactant and a co-surfactant. The cationic surfactant has the structural formula:

wherein: R1 is an alkyl group or alkenyl group having from 5 to 22 carbon atoms, R2 and R3 are alkyl groups having from 1 to 6 carbon atoms, R4 is a hydrogen atom or an alkyl group having from 1 to 6 carbon atoms, and X— is selected from the group of a carboxylate, an acrylate, a methacrylate, a halide, a phosphonate, a sulfate, a sulfonate, a hydroxide, a carbonate, or any combination thereof; and The co-surfactant is present in the inhibitor blend in an amount of no greater than about 10 percent by weight based on the total weight of the blend.

First claim

What is claimed is:

1. A low dosage hydrate inhibitor blend consisting essentially of:
a cationic surfactant, wherein said cationic surfactant has the structural formula:

wherein: R 1 is an alkyl group or alkenyl group having from 5 to 22 carbon atoms, R 2 and R 3 are alkyl groups having from 1 to 6 carbon atoms, R 4 is a hydrogen atom or an alkyl group having from 1 to 6 carbon atoms, and X— is a carboxylate, an acrylate, a methacrylate, a halide, a phosphonate, a sulfate, a sulfonate, a hydroxide, a carbonate, or any combination thereof; and
a co-surfactant, wherein said co-surfactant is present in the inhibitor blend in an amount of no greater than about 10 percent by weight based on the total weight of said blend.

2. The low dosage hydrate inhibitor blend of claim 1 , wherein the cationic surfactant has the structural formula (1), shown below:

wherein: R 1 is an alkyl group having from 11 to 17 carbon atoms, R 2 and R 3 are alkyl groups having from 1 to 4 carbon atoms, R 4 is a hydrogen atom or an alkyl group having from 1 to 2 carbon atoms, and X— is a sulfonate, a carbonate, or any combination thereof.

3. The low dosage hydrate inhibitor blend of claim 1 , wherein said co-surfactant is present in the inhibitor blend in an amount in the range of from about 0.01% by weight to about 10% by weight, based on the total weight of the inhibitor blend.

4. The low dosage hydrate inhibitor blend of claim 1 , wherein said co-surfactant includes at least one polyetheramine.

5. The low dosage hydrate inhibitor blend of claim 1 , wherein said co-surfactant consists essentially of a mixture of two or more polyetheramines.

6. The low dosage hydrate inhibitor blend of claim 4 , wherein the amino group of said polyetheramine(s) is a primary amino group.

7. The low dosage hydrate inhibitor blend of claim 4 , wherein the polyether backbone of said polyetheramine(s) can be based on propylene oxide, ethylene oxide, or a combination thereof.

8. The low dosage hydrate inhibitor blend of claim 4 , wherein said polyetheramine(s) is selected from the group consisting of compounds that include one or more primary or secondary monoamines, diamines or triamines attached to one or both ends of a polyether backbone, and any combination of such compounds.

9. The low dosage hydrate inhibitor blend of claim 4 , wherein said polyetheramine(s) is a compound that includes a primary diamine attached to an end of a polyether backbone that is based on propylene oxide or ethylene oxide.

10. The low dosage hydrate inhibitor blend of claim 4 , wherein said polyetheramine(s) is selected from the group consisting of a polyoxypropylene diamine, a 3,6-dioxaoctamethylenediamine, and mixtures thereof.

11. A method of treating a well fluid, comprising:
combining a low dosage hydrate inhibitor blend with the well fluid, said low dosage inhibitor blend consists essentially of:
a cationic surfactant, wherein said cationic surfactant has the structural formula:

wherein: R 1 is an alkyl group or alkenyl group having from 5 to 22 carbon atoms, R 2 and R 3 are alkyl groups having from 1 to 6 carbon atoms, R 4 is a hydrogen atom or an alkyl group having from 1 to 6 carbon atoms, and X— a carboxylate, an acrylate, a methacrylate, a halide, a phosphonate, a sulfate, a sulfonate, a hydroxide, a carbonate, or any combination thereof; and
a co-surfactant, wherein said co-surfactant is present in the inhibitor blend in an amount of no greater than about 10 percent by weight based on the total weight of said blend.

12. The method of claim 11 , wherein said co-surfactant includes at least one polyetheramine.

13. The method of claim 11 , wherein the well fluid includes a fluid produced from a well.

14. The method of claim 11 , wherein the well fluid includes a hydrocarbon or a fluid that has or will come into contact with a hydrocarbon.

15. The method of claim 11 , wherein the well fluid includes natural gas.

16. The method of claim 11 , wherein the well fluid includes a mixture of a liquid hydrocarbon and water, and wherein said mixture has a water cut of greater than about 5%.

17. The method of claim 11 , wherein the well fluid includes a mixture of a hydrocarbon and water, and wherein said water includes condensed water.

18. The method of claim 11 , wherein the well fluid is associated with an oil and gas well production system.

19. A method of treating a well fluid associated with an oil and gas well production system, comprising:
combining a low dosage hydrate inhibitor blend with the well fluid, said low dosage inhibitor blend consisting essentially of:
a cationic surfactant, wherein said cationic surfactant has the structural formula:

wherein: R 1 is an alkyl group or alkenyl group having from 5 to 22 carbon atoms, R 2 and R 3 are alkyl groups having from 1 to 6 carbon atoms, R 4 is a hydrogen atom or an alkyl group having from 1 to 6 carbon atoms, and X— a carboxylate, an acrylate, a methacrylate, a halide, a phosphonate, a sulfate, a sulfonate, a hydroxide, a carbonate, or any combination thereof; and
a co-surfactant, wherein said co-surfactant is present in the inhibitor blend in an amount of no greater than about 10 percent by weight, based on the total weight of said blend, and includes at least one polyetheramine.

20. The method of claim 19 , wherein said low dosage hydrate inhibitor blend is combined with the well fluid using mixing equipment.

Assignees

• Halliburton Energy Services Inc

Inventors

• Monteiro Deepak S
• Lan Qiang
• Vo Loan
• Prince Philippe

Classifications

• C10L3/107 Primary

  Limiting or prohibiting hydrate formation · CPC title

• C09K8/52 Primary

  Compositions for preventing, limiting or eliminating depositions, e.g. for cleaning · CPC title

• C09K2208/22

  Hydrates inhibition by using well treatment fluids containing inhibitors of hydrate formers · CPC title